Graham Fleming, Chief Executive Officer of Finance of America Companies Inc., acquired 200,000 stock options on December 19, 2025. These options, which grant the right to buy Class A Common Stock, have an exercise price of $25.00 and an expiration date of December 19, 2030. The options vest in three equal increments on...

This filing details a transaction by Paul Joseph Gallagher, Chief Supply Chain Officer of GENERAL MILLS INC. On December 19, 2025, Gallagher disposed of 1500 shares of Common Stock at a price of $48.1539 per share, resulting in a post-transaction share count of 48,568.2372. Additionally, 331.41 shares of Common Stock a...

This filing details a transaction by GEORGE JENNIFER L, SEVP and COO of CB Financial Services, Inc. (CBFV), on December 19, 2025. The transaction involved the disposal of 125 shares of Common Stock at a price of $36.39 per share, resulting in 12,160 shares held post-transaction. The filing also reports holdings of vari...

This Form 4 filing details a transaction by John Gill, a director at Altimmune, Inc. On December 23, 2025, Mr. Gill acquired 12,500 shares of the company's common stock through a purchase transaction (Code "P"). The price per share was $4.10, resulting in a total transaction value of $51,250. Following this transaction...

Global GP LLC, the General Partner of GLOBAL PARTNERS LP, reported several transactions involving common units representing limited partner interests. On December 19, 2025, 2,000 units were acquired at a weighted average price of $42.66. On December 22, 2025, 1,250 units were acquired at a weighted average price of $42...

This filing details transactions made by Lawrence A. Hilsheimer, EVP and CFO of Greif, Inc., on December 19, 2025. Hilsheimer disposed of a total of 1776 shares of Class A Common Stock through multiple transactions, all marked with transaction code "G" and a price per share of 0.0. These dispositions resulted in post-t...

This filing details a Form 4 submission by Seth L. Kaplan, Sr. VP, General Counsel and Secretary of GRIFFON CORP (GFF). On December 22, 2025, Kaplan disposed of 600 shares of Common Stock. The transaction code was 'G' and the disposal code was 'D', indicating a disposition of shares. Post-transaction, Kaplan holds 134,...

Ciena Corporation Senior Vice President of Global Products & Supply, Gage Brodie, filed a Form 4 disclosing the sale of 6,678 shares of common stock on December 20, 2025. The transactions were executed at $230.34 per share and represent shares withheld to cover tax liabilities associated with multiple restricted stock ...

This filing details a transaction by Paul Joseph Gallagher, Chief Supply Chain Officer of GENERAL MILLS INC. On December 19, 2025, Gallagher disposed of 1500 shares of Common Stock at a price of $48.1539 per share, resulting in a post-transaction share count of 48,568.2372. Additionally, 331.41 shares of Common Stock a...

Gandhi Anand, Chief Financial Officer of Eventbrite, Inc., reported a disposition of 320,073 shares of Class A Common Stock on December 19, 2025. The shares were sold at a price of $4.43 per share. Following this transaction, Anand directly owns 913,556 shares. A footnote indicates that some shares were withheld by the...

Charles K. Gayer, President and CCO of BioCryst Pharmaceuticals Inc (BCRX), filed a Form 4 reporting significant stock transactions between December 19-22, 2025. On December 19, Gayer disposed of 11,477 shares at $7.41 per share through tax withholding for vested restricted stock units. On December 22, he exercised thr...

This filing details transactions of Common Stock by James P. Geary II, a director at Burke & Herbert Financial Services Corp. On June 26, 2025, 15,550 shares were acquired with the transaction code 'W', resulting in 33,468 shares post-transaction, with indirect ownership. An additional 12,607 shares were acquired on Oc...

This Form 4 filing reports a transaction by Wilson William R Jr., a director at Genprex, Inc. On December 22, 2025, Mr. Wilson acquired 9,000 shares of Common Stock. This acquisition was made under the company's 2018 Equity Incentive Plan, with the Restricted Stock Units (RSUs) vesting fully on the earlier of August 15...

This filing details a stock transaction by Brent Longnecker, a director at Genprex, Inc. On December 22, 2025, Longnecker acquired 9,000 shares of Common Stock under the Genprex, Inc. 2018 Equity Incentive Plan. These shares will vest on the earlier of August 15, 2026, or the day prior to the company's next annual meet...

Jose Antonio Moreno Toscano, a director at Genprex, Inc., acquired 9,000 shares of Common Stock on December 22, 2025, with a transaction price of $0.00. This acquisition was part of an award of Restricted Stock Units (RSUs) under the company's 2018 Equity Incentive Plan. The RSUs vest fully on the earlier of August 15,...

Andrew Shafer, Chief Cust Mkt & Brnd Officer at Gevo, Inc. (GEVO), reported a sale of 5,000 shares of Common Stock on December 22, 2025, under a 10b5-1 trading plan. The weighted average sale price was $2.1947 per share, with individual sales ranging from $2.175 to $2.21. Following this transaction, Shafer directly own...

Edward Oliver Gillespie, Chief Executive Officer and Director of ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG), reported two open market purchases of the company's common stock. On December 19, 2025, Gillespie acquired 8,461 shares at a weighted average price of $1.65 per share. Subsequently, on December 22, 2025, he purcha...

This filing details a transaction by Roland A. Giroux, Executive Vice President, Chief Legal Officer and Corporate Secretary of Acushnet Holdings Corp. On December 19, 2025, Mr. Giroux acquired 141.46 shares of Common Stock under the Issuer's deferred compensation plan, specifically related to dividend equivalent right...

This SEC Form 4 filing reports that Matthew Jacobson, a director of GitLab Inc. (GTLB), sold 334,827 shares of Class A Common Stock on December 19, 2025, at a weighted average price of $38.0789 per share. The shares were sold through ICONIQ Investment Holdings, LP, with transactions occurring at prices ranging from $37...

Global GP LLC, the General Partner of GLOBAL PARTNERS LP, reported several transactions involving common units representing limited partner interests. On December 19, 2025, 2,000 units were acquired at a weighted average price of $42.66. On December 22, 2025, 1,250 units were acquired at a weighted average price of $42...

This Form 4 filing details a transaction by Gong Xunkai, Executive Chairman and Director of AvePoint, Inc. (AVPT). On December 19, 2025, Mr. Xunkai disposed of 6,500 shares of the company's common stock. The transaction code 'F' indicates an exempt transaction related to the satisfaction of tax liabilities through the ...

Lisa Gorman, General Counsel at Eventbrite, Inc., reported a disposition of 77,483 shares of Class A Common Stock on December 19, 2025. The shares were sold at a price of $4.43 per share. This transaction, coded as 'F' (fee payment), resulted in 564,486 shares remaining in her ownership, held directly. A footnote indic...

This filing details a transaction by Graboske Benjamin, EVP, Chief Data Officer of Definitive Healthcare Corp. On December 22, 2025, Benjamin Graboske disposed of 341,417 shares of Class A Common Stock at a price of $2.53 per share, resulting in a post-transaction holding of 676,913 shares. The shares disposed of were ...

This filing details a transaction by Ashley B. Griffith, a director at BIMINI CAPITAL MANAGEMENT, INC. On December 19, 2025, Griffith acquired 50,000 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Griffith directly owns 50,000 shares of the company's stock. The transaction cod...

Roberto Mignone, a director at Guardant Health, Inc., reported a disposition of 264 shares of Common Stock on December 21, 2025. The transaction code "M" indicates a grant, and the disposition code "D" suggests these shares were part of a Restricted Stock Unit (RSU) award. The RSUs were granted on November 8, 2024, and...